SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that its Board of
Directors has elected Dominic Caruso as a new independent director,
effective September 12, 2018. With the election of Dominic Caruso,
McKesson’s Board of Directors increases from eight to nine members,
eight of whom are independent.
“Dominic’s three decades of global financial and operational experience,
leadership, and tenure in the healthcare industry make him an ideal
addition to our Board of Directors,” said John H. Hammergren, chairman
and chief executive officer, McKesson Corporation. “His demonstrated
commitment to rigorous financial stewardship complements McKesson’s
dedication to strong financial management, disciplined growth and
strategic capital allocation.”
“I'm delighted to be joining a company that I've long admired and look
forward to adding my perspective and contributing to the company's
future development and success,” added Dominic Caruso. “McKesson’s
market leadership and deep customer and partner relationships position
it for long-term growth in the healthcare industry. I look forward to
helping chart the company’s path forward.”
Dominic Caruso
Dominic Caruso, age 61, retired as executive vice president and chief
financial officer from Johnson & Johnson in August 2018, having served
in the role since 2007. Dominic led the company’s financial and investor
relations activities, as well as the procurement organization. Dominic
joined Johnson & Johnson in October 1999 as chief financial officer for
Centocor, Inc., upon the completion of the merger of Centocor and
Johnson & Johnson. Prior to joining Centocor, he had varied industry
experiences with KPMG.
Dominic is actively involved in government relations activities
globally, including having served as the co-chair of the U.S. Chamber of
Commerce Global Initiative on Health and the Economy. He currently
serves on the Board of Trustees of The Children’s Hospital of
Philadelphia and the Cystic Fibrosis Foundation.
McKesson’s Board has appointed Dominic to its Audit Committee and its
Finance Committee.
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
“Best
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit www.mckesson.com.
